Literature DB >> 35189667

A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination.

Jeffrey V Lazarus1,2, Camila A Picchio1, Christopher J Byrne3, Javier Crespo4, Massimo Colombo5, Graham S Cooke6, Gregory J Dore7, Jason Grebely7, John W Ward8, John F Dillon3,9.   

Abstract

Microelimination targets specific subpopulations and/or geographic settings for hepatitis C virus (HCV) elimination. This review reports on global HCV microelimination literature published from 2013 to 2020. Data were extracted from publications to report a score based on the four key components defining microelimination. Sustained virologic response (SVR) and treatment initiation proportions were calculated for each manuscript and grouped means of these estimates were compared depending on microelimination score and care setting. A total of 83% of the studies were from high-income settings and mainly included people who use drugs or those incarcerated. Among manuscripts, 18 had "low" microelimination scores, 11 had "high" scores, and the differences in mean proportion who initiated treatment and achieved SVR between low and high score groups were statistically significant. Microelimination can be a useful complementary strategy for driving engagement in HCV treatment and cure. Our analysis suggests that adhering to more of the core microelimination components can improve outcomes. This study is registered with Prospero, registration identification: CRD42020175211. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35189667     DOI: 10.1055/a-1777-6112

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.512


  2 in total

1.  Ten steps to eliminating hepatitis C in hospitals.

Authors:  José Luis Calleja; Antonio Aguilera; Maria Buti; Javier Crespo; Federico García; Francisco Jorquera; Luis Enrique Morano; Juan Macias; Jeffrey V Lazarus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-08       Impact factor: 73.082

2.  Altered hepatitis C testing and treatment beyond the COVID-19 pandemic.

Authors:  Hamidreza Karimi-Sari; Mohammad Saeid Rezaee-Zavareh
Journal:  Public Health       Date:  2022-05-11       Impact factor: 4.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.